Filing Details

Accession Number:
0001140361-23-004733
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-02-06 17:41:27
Reporting Period:
2023-02-02
Accepted Time:
2023-02-06 17:41:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1034842 Rigel Pharmaceuticals Inc RIGL Pharmaceutical Preparations (2834) 943248524
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1820066 A David Santos Rigel Pharmaceuticals, Inc.
611 Gateway Blvd, Suite 900
South San Francisco CA 94080
Evp, Chief Commercial Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-02-02 5,388 $1.66 144,612 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. These shares were sold to cover tax withholding due upon vesting of Restricted Stock Units. Such "sales to cover" were automatically effected to satisfy tax withholding obligations and do not represent a discretionary trade by the Reporting Person.